Thiago Jessé Kucarz

Thiago Jessé Kucarz

Auto-generated profile, based on publicly available information

Thiago Jessé Kucarz

Universidade Estadual de Campinas, Brasil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
TKThiago Jessé Kucarz
Thiago Jessé Kucarz
CSCintia Avila Souza
Cintia Avila Souza
SHSimone Aiko Hatanaka
Simone Aiko Hatanaka
ESElisa Nunes Secamilli
Elisa Nunes Secamilli
MDMarina Rovani Drummond
Marina Rovani Drummond
PVPaulo Velho
Paulo Velho
Currently, at least 22 species of Bartonella are known to cause diseases in humans, with Bartonella henselae being the main one. Among the clinical manifestations associated with bartonellosis, cutaneous vasculitis is rare, but it can be severe. We report the case of a 9-year-old child who presented with cervical lymphadenopathy, arthritis, epididymitis, and cutaneous vasculitis as clinical manifestations of systemic bartonellosis, with positive detection of B. henselae in blood and skin fragment using species-specific conventional polymerase chain reaction (PCR) techniques. Vasculitis caused by Bartonella spp. occurs due to the endothelial tropism of the bacteria and can mimic systemic vasculitis with positive anti-neutrophil cytoplasmic antibodies (ANCA). Furthermore, we found just one previous report about epididymitis related to B. henselae infection, and arthritis is also considered an unusual manifestation of the infection. This case emphasizes the need to consider bartonellosis among differential diagnoses when faced with presentations of purpura, cutaneous vasculitis, arthritis, or epididymitis.

1 January 2025 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
LGLuciana Vilela Gomide
Luciana Vilela Gomide
JBJoão Paulo Brufatto
João Paulo Brufatto
TKThiago Jessé Kucarz
Thiago Jessé Kucarz
PVPaulo Velho
Paulo Velho
AFAndréa Fernandes Eloy da Costa França
Andréa Fernandes Eloy da Costa França
Background: Erythema nodosum leprosum (ENL) is an immunological inflammatory reaction requiring precise management. Recalcitrant cases, their refractoriness to conventional therapy, and the adverse effects of standard treatments underline the need to explore alternative therapeutic options. Methods: We conducted a retrospective study of five patients treated with secukinumab between January 2023 and January 2025. Results: Patients showed clinical improvement with a reduced ENL frequency, neuritis relief, and corticosteroid sparing. Conclusions: Secukinumab appears to be a promising corticosteroid-sparing option for ENL, with a favorable safety profile. Further studies are required to confirm the efficacy and long-term safety of this treatment regimen.